3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
7
Ovarian Neoplasms
5
Fallopian Tube Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Pancreatic Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Mycosis Fungoides
2
Multiple Myeloma
2
Mouth Neoplasms
2
Melanoma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Colonic Neoplasms
2
Carcinoma
2
Brenner Tumor
2
Breast Neoplasms
2
Adenocarcinoma of Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
6
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Specimen Handling
4
Biopsy
4
Vincristine
3
Cyclophosphamide
3
Cisplatin
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Temozolomide
2
Radiotherapy
2
Radiation
2
Platinum
2
Lomustine
2
1,2-diaminocyclohexaneplatinum II citrate
2
tazemetostat
1
palbociclib
1
lutetium Lu 177 dotatate
1
Vemurafenib
1
Vascular Endothelial Growth Factor A
1
Triiodothyronine
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Immunoglobulin G
×
30 days
×
Clear all
No trials found.